NPRL2
Basic information
Region (hg38): 3:50347330-50350826
Previous symbols: [ "TUSC4" ]
Links
Phenotypes
GenCC
Source:
- epilepsy, familial focal, with variable foci 2 (Moderate), mode of inheritance: AD
- epilepsy, familial focal, with variable foci 2 (Strong), mode of inheritance: AD
- familial focal epilepsy with variable foci (Supportive), mode of inheritance: AD
- familial focal epilepsy with variable foci (Moderate), mode of inheritance: AD
- focal epilepsy (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epilepsy, familial focal, with variable foci 2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 26505888; 27173016 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (58 variants)
- Inborn_genetic_diseases (41 variants)
- Epilepsy,_familial_focal,_with_variable_foci_2 (38 variants)
- NPRL2-related_disorder (8 variants)
- not_specified (8 variants)
- Seizure (4 variants)
- Neonatal_respiratory_distress (1 variants)
- Familial_focal_epilepsy_with_variable_foci (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPRL2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006545.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 80 | 92 | ||||
nonsense | 6 | |||||
start loss | 1 | 1 | ||||
frameshift | 10 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 10 | 15 | 82 | 13 | 1 |
Highest pathogenic variant AF is 0.00000205266
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPRL2 | protein_coding | protein_coding | ENST00000232501 | 11 | 3762 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.388 | 0.612 | 125727 | 0 | 13 | 125740 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 155 | 224 | 0.692 | 0.0000133 | 2493 |
Missense in Polyphen | 49 | 82.55 | 0.59358 | 873 | ||
Synonymous | 0.413 | 84 | 89.0 | 0.944 | 0.00000508 | 722 |
Loss of Function | 3.40 | 5 | 22.4 | 0.223 | 0.00000113 | 251 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000616 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the TORC1 pathway. The GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB within RRAGC-containing heterodimers, thereby deactivating RRAGs, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signaling. The GATOR1 complex is negatively regulated by GATOR2 the other GATOR subcomplex in this amino acid-sensing branch of the TORC1 pathway. {ECO:0000269|PubMed:23723238}.;
- Disease
- DISEASE: Epilepsy, familial focal, with variable foci 2 (FFEVF2) [MIM:617116]: An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions, including the temporal, frontal, parietal, and occipital lobes. Seizure types commonly include temporal lobe epilepsy, frontal lobe epilepsy, and nocturnal frontal lobe epilepsy. Some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. A subset of patients have structural brain abnormalities. Penetrance of the disorder is incomplete. {ECO:0000269|PubMed:26505888, ECO:0000269|PubMed:27173016}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.15
Haploinsufficiency Scores
- pHI
- 0.217
- hipred
- Y
- hipred_score
- 0.613
- ghis
- 0.607
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nprl2
- Phenotype
- vision/eye phenotype; hematopoietic system phenotype; embryo phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- protein phosphorylation;cellular response to nitrogen starvation;positive regulation of autophagy;negative regulation of TOR signaling;negative regulation of kinase activity;cellular response to amino acid starvation;positive regulation of GTPase activity;regulation of autophagosome assembly
- Cellular component
- lysosomal membrane;GATOR1 complex
- Molecular function
- protein kinase activity;GTPase activator activity;protein binding